Upstream Bio, Inc.
UPB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 |
| % Growth | -0.4% | 96.4% | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | -3,277.4% | -1,682.9% | -1,972.1% |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | -2,650% | -862.9% | -1,969.3% |
| EPS Diluted | -1.49 | -1.05 | -0.66 |
| % Growth | -41.9% | -59.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 |